Navigation Links
Henry Schein to Present at the UBS 20th Annual Global Healthcare Services Conference
Date:2/4/2010

MELVILLE, N.Y., Feb. 4 /PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Henry Schein's Chairman & Chief Executive Officer, and Steven Paladino, the Company's Executive Vice President and Chief Financial Officer, will present at the UBS 20th Annual Global Healthcare Services Conference on Monday, February 8, 2010.  The Conference is being held at the Grand Hyatt in New York City.  

Henry Schein's presentation is scheduled to begin at 3 p.m. ET and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."   A replay will be available on the Web site following the presentation.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is the largest provider of health care products and services to office-based practitioners.  Recognized for its excellent customer service and highly competitive prices, the Company's four business groups – Dental, Medical, International and Technology – serve approximately 590,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions.  Henry Schein operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.  Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.  

Headquartered in Melville, N.Y., Henry Schein employs more than 13,500 people and has operations or affiliates in 23 countries.  The Company's net sales reached a record $6.4 billion in 2008.  For more information, visit the Henry Schein Web site at www.henryschein.com.

SOURCE Henry Schein, Inc.

RELATED LINKS
http://www.henryschein.com

'/>"/>

SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference
2. Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors
3. Henry Schein Works With Supplier Partners to Earmark $1 Million in Health Care Supplies for Haiti Earthquake Relief
4. Henry Schein to Present at the NASDAQ OMX 23rd Investor Program
5. Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii
6. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
7. Pulse Systems Announces New Sales Representation in the Western United States
8. CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference
9. ADVENTRX Appoints Icahn Representative to Board of Directors
10. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. West to Present at UBS Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):